Patients presenting with skeletal metastatic lesions requiring surgery are increasing, this is due to an ageing population and improved oncological survival following advances in medical management. Furthermore, patients are living longer with skeletal metastatic disease. The majority of bone metastases occur in the proximal femur. Robust diagnosis (Biopsy) and treatment is required to ensure that patients can mobilise fully weight bearing immediately post-surgery and that the construct should outlive the patients expected survival. We review the changing management of metastatic disease in the proximal femur.
Hip Int 2017; 27(1): 1 - 7
Article Type: REVIEW
AuthorsSam C. Jonas, Sanchit M. Mehendale, Simon M. Bick, Richard P. Baker
- • Accepted on 18/01/2017
- • Available online on 08/02/2017
- • Published in print on 21/02/2017
This article is available as full text PDF.
- Jonas, Sam C. [PubMed] [Google Scholar]
- Mehendale, Sanchit M. [PubMed] [Google Scholar]
- Bick, Simon M. [PubMed] [Google Scholar]
- Baker, Richard P. [PubMed] [Google Scholar] , * Corresponding Author (email@example.com)
Avon Orthopaedic Centre, North Bristol NHS Trust, Bristol - UK